Marty is SVP, Global Head of Digital Medicine & Regulatory Innovation at EVERSANA, where he helps companies understand the dynamic landscape within digital medicine as they approach regulatory authorities and seek to commercialize their products. He is a digital medicine and digital therapeutics veteran who has developed and launched innovative products targeting oncology, Alzheimer’s, autoimmune disease, and asthma via various regulatory and commercial pathways, has designed digital therapeutics clinical trials and commercial pilot studies, and has supported more than 50 companies over the past two years on regulatory strategy and submissions, reimbursement, market access, and commercial strategy. As an indicator of his passion for innovation in digital medicine, he has been granted more than 10 breakthrough device designations by FDA for digital therapeutics and digitally-enabled medical devices.